Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Assessing a new device to reduce complications from intravenous catheters

Official title: A Non-Inferiority Randomized Clinical Trial Investigating Efficacy and Safety of an Innovative Medical Device in the Reduction of Mechanical Complications of Peripheral Intravenous Catheters

Run by Interlinked AB · NCT06727240 · Data updated 2026-11-12

This study is testing a new device to see if it can help reduce problems caused by IV catheters in hospitalized patients.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment548 (estimated)
SponsorInterlinked AB
Industry-sponsored
Locations2 sites (Coimbra and 1 other locations)
StatusRecruiting
StartedMarch 25, 2024
Main results expectedDecember 2024
Study endsMarch 2025
Registry record updatedDecember 16, 2024
Trial IDNCT06727240 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who require a vascular access device for continuous or intermittent IV infusion therapy.

Probably not a fit

Patients who are pregnant, under palliative care, or those requiring a vascular access device solely for sampling will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a new medical device designed to minimize mechanical complications associated with peripheral intravenous catheters (PIVCs), which are commonly used in hospitalized patients. It will involve a non-inferiority randomized trial across two sites, recruiting a total of 548 patients. The primary focus will be on measuring complication rates, while secondary outcomes will include adverse events, healthcare feedback, and economic impacts related to the use of the device. The study aims to address the high failure rates of PIVCs, which can lead to significant patient discomfort and healthcare costs.

Why it matters

Potential benefit: If successful, this study could significantly reduce the rates of complications associated with intravenous access, improving patient comfort and outcomes.

How similar studies have gone: Previous studies have indicated that addressing mechanical irritation may reduce PIVC failure rates, suggesting that this approach has potential based on existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The patient has or will get a vascular access device (VAD) expected to be used for continuous or intermittent IV infusion therapy. Continuous IV infusion is defined as an infusion ≥2h and intermitted as an infusion lasting 15min to \<2h.
* ≥18 years of age
* Speak and understand local language
* VADs already in place when the patient is admitted to the ward should not present with phlebitis or infiltration or occlusion
* Participants have signed the informed consent or have a legal authorized representative (LAR) who has provided this consent

Exclusion Criteria:

* The VAD is expected to be used for sampling only
* Pregnancy
* Unable to obtain informed consent or without an available LAR to provide surrogate informed consent
* Patients under palliative care
* Bolus IV infusion, defined as an infusion time of \<15 min

Where it's running

  • Centro Hospitalar e Universitário de Coimbra
    Coimbra, Portugal
    Recruiting
  • Parc Sanitari Sant Joan de Déu
    Barcelona, Spain
    Completed

Study contacts

  • Principal investigator: Ramon Mir Abellán, PhD — Parc Sanitari Sant Joan de Déu
  • Study coordinator: Christopher Blacker, Medical Doctor
  • Email: christopher.blacker@uu.com
  • Phone: +46737301399

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.